← Eichor
Study identifier: NCT07321652 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Leukemia  ·  Sponsor: Alliance for Clinical Trials in Oncology

PhasePhase 3
Planned participants466
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

This phase III trial compares the effect of adding sonrotoclax to zanubrutinib versus zanubrutinib alone for the treatment of patients with untreated chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL). Sonrotoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Zanubrutinib is in a class of medications called kinase inhibitors. It blocks a protein called BTK, which is present on B-cell (a type of white blood cells) cancers such as mantel cell lymphoma at abnormal levels. This may help keep cancer cells from growing and spreading. Giving sonrotoclax and zanubrutinib may be more effective than zanubrutinib alone for the treatment of untreated CLL/SLL.

This description comes directly from the study's public registry record.

Talk to the study team

Jayke Giese  ·  773-702-9171  ·  leukemiaprotocols@alliancenctn.org

Always discuss trial participation with your own doctor first.

Locations (152)

Cedars-Sinai Medical CenterLos Angeles, California, United StatesRecruiting
Jupiter Medical CenterJupiter, Florida, United StatesRecruiting
Saint Alphonsus Cancer Care Center-BoiseBoise, Idaho, United StatesRecruiting
Saint Alphonsus Cancer Care Center-CaldwellCaldwell, Idaho, United StatesRecruiting
Kootenai Health - Coeur d'AleneCoeur d'Alene, Idaho, United StatesRecruiting
Idaho Urologic Institute-MeridianMeridian, Idaho, United StatesRecruiting
Saint Alphonsus Cancer Care Center-NampaNampa, Idaho, United StatesRecruiting
Kootenai Clinic Cancer Services - Post FallsPost Falls, Idaho, United StatesRecruiting
Kootenai Clinic Cancer Services - SandpointSandpoint, Idaho, United StatesRecruiting
Illinois CancerCare-BloomingtonBloomington, Illinois, United StatesRecruiting
Illinois CancerCare-CantonCanton, Illinois, United StatesRecruiting
Illinois CancerCare-CarthageCarthage, Illinois, United StatesRecruiting

+ 140 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07321652